AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of investor meet scheduled on 13.06.2024.06-06-2024
06-06-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor meet scheduled to be held on 11.06.2024.06-06-2024
AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificates.03-06-2024
Aurobindo Pharma secures marketing authorisation for Trastuzumab biosimilar in India
The drug is indicated in the treatment of certain types of breast cancer03-06-2024
Hot Stocks: Brokerages view on Aurobindo Pharma, Apollo Hospitals, Suzlon & Titan Company
Top brokerage firms like Macquarie maintained an outperform rating on Aurobindo Pharma, raising the target price to Rs 1,385. Aurobindo Pharma signed a master service agreement with Merck Sharp & Dohme, leading to a biologics CMO contract with TheraNym.03-06-2024
Aurobindo Pharma Unit Partners With MSD For Contract Manufacturing Venture
Theranym will invest around Rs 1,000 crore for establishing manufacturing facility with capacity of up to 25-30 million vials per annum.31-05-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Submission of transcript of earnings call held on May 27, 2024 on audited financial results for the fourth quarter and year ended on March 31, 2024.31-05-2024
AUROBINDO PHARMA LTD. - 524804 - Execution Of Master Service Agreement Between Merck Sharpe & Dohme Singapore Trading Pte. Ltd. (MSD) And Theranym Biologics Private Limited, A Wholly Owned Subsidiary
Intimation of execution of Master Service Agreement signed between Merck Sharpe & Dohme Singapore Trading Pte. Ltd and TheraNym Biologics Private Limited, a wholly owned subsidiary of the Company.31-05-2024
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of participation in Investor Meet31-05-2024
AUROBINDO PHARMA LTD. - 524804 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate28-05-2024